Design, synthesis and biological evaluation of benzylisoquinoline derivatives as multifunctional agents against Alzheimer's disease.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Bioorganic & Medicinal Chemistry Letters

• Publication date

  2014-05-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.bmcl.2014.03.058PMID 24726809
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Design, synthesis and evaluation of flavonoid derivatives as potential multifunctional acetylcholinesterase inhibitors against Alzheimer's disease.

  2013cited by this paper
• The discovery of fused oxadiazepines as gamma secretase modulators for treatment of Alzheimer's disease.

  2013cited by this paper
• Design, synthesis and biological activity of multifunctional α,β-unsaturated carbonyl scaffolds for Alzheimer's disease.

  2013cited by this paper
• Design and synthesis of bicyclic heterocycles as potent γ-secretase modulators.

  2013cited by this paper
• Novel tacrine-related drugs as potential candidates for the treatment of Alzheimer's disease.

  2013cited by this paper
• Aza-BODIPY: improved synthesis and interaction with soluble Aβ1-42 oligomers.

  2013cited by this paper
• Synthesis of new antimicrobial pyrrolo[2,1-a]isoquinolin-3-ones.

  2012cited by this paper
• Structure- and property-based design of aminooxazoline xanthenes as selective, orally efficacious, and CNS penetrable BACE inhibitors for the treatment of Alzheimer's disease.

  2012cited by this paper
• Design, synthesis, and evaluation of indanone derivatives as acetylcholinesterase inhibitors and metal-chelating agents.

  2012cited by this paper
• First enantioselective syntheses of the dopamine D1 and D2 receptor modulators, (+)- and (-)-govadine.

  2012cited by this paper
• Bioactive isoquinoline alkaloids from Corydalis saxicola.

  2012cited by this paper
• Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.

  2012cited by this paper
• New tacrine-4-oxo-4H-chromene hybrids as multifunctional agents for the treatment of Alzheimer's disease, with cholinergic, antioxidant, and β-amyloid-reducing properties.

  2012cited by this paper
• Syntheses and characterization of novel oxoisoaporphine derivatives as dual inhibitors for cholinesterases and amyloid beta aggregation.

  2011cited by this paper
• Design, synthesis, and biological evaluation of curcumin analogues as multifunctional agents for the treatment of Alzheimer's disease.

  2011cited by this paper
• Evaluation of bactericidal and fungicidal activity of ferrocenyl or phenyl derivatives in the diphenyl butene series

  2011cited by this paper
• Total Synthesis of New 8‐(Arylmethyl)berbines

  2010cited by this paper
• Alzheimer's disease.

  2010cited by this paper
• Novel tacrine-8-hydroxyquinoline hybrids as multifunctional agents for the treatment of Alzheimer's disease, with neuroprotective, cholinergic, antioxidant, and copper-complexing properties.

  2010cited by this paper
• Effect of isoquinoline alkaloids from two Hippeastrum species on in vitro acetylcholinesterase activity.

  2010cited by this paper
• Site-activated multifunctional chelator with acetylcholinesterase and neuroprotective-neurorestorative moieties for Alzheimer's therapy.

  2009cited by this paper
• Exploiting protein fluctuations at the active-site gorge of human cholinesterases: further optimization of the design strategy to develop extremely potent inhibitors.

  2008cited by this paper
• Lead identification of acetylcholinesterase inhibitors-histamine H3 receptor antagonists from molecular modeling.

  2008cited by this paper
• Crystal structure of thioflavin T bound to the peripheral site of Torpedo californica acetylcholinesterase reveals how thioflavin T acts as a sensitive fluorescent reporter of ligand binding to the acylation site.

  2008cited by this paper
• Cholinesterase inhibitors: SAR and enzyme inhibitory activity of 3-[omega-(benzylmethylamino)alkoxy]xanthen-9-ones.

  2007cited by this paper
• A small molecule targeting the multifactorial nature of Alzheimer's disease.

  2007cited by this paper
• Insight Into the Kinetic of Amyloid β (1–42) Peptide Self‐Aggregation: Elucidation of Inhibitors’ Mechanism of Action

  2007cited by this paper
• Isoquinoline derivatives as potential acetylcholinesterase inhibitors.

  2006cited by this paper
• Targeting beta-amyloid pathogenesis through acetylcholinesterase inhibitors.

  2006cited by this paper
• Dimeric and hybrid anti-Alzheimer drug candidates.

  2006cited by this paper
• Acetylcholinesterase inhibitors from Stephania venosa tuber

  2006cited by this paper
• Homobivalent quinazolinimines as novel nanomolar inhibitors of cholinesterases with dirigible selectivity toward butyrylcholinesterase.

  2006cited by this paper
• Propidium-based polyamine ligands as potent inhibitors of acetylcholinesterase and acetylcholinesterase-induced amyloid-beta aggregation.

  2005cited by this paper
• Treatment of Alzheimer's disease: current and future therapeutic approaches.

  2004cited by this paper
• Peripheral and dual binding site inhibitors of acetylcholinesterase as neurodegenerative disease modifying agents

  2003cited by this paper
• Specific targeting of acetylcholinesterase and butyrylcholinesterase recognition sites. Rational design of novel, selective, and highly potent cholinesterase inhibitors.

  2003cited by this paper
• Structure-activity relationships of acetylcholinesterase noncovalent inhibitors based on a polyamine backbone. 2. Role of the substituents on the phenyl ring and nitrogen atoms of caproctamine.

  2003cited by this paper
• Treatment of Alzheimer's disease: current status and new perspectives.

  2003cited by this paper
• A New Therapeutic Target in Alzheimer's Disease Treatment: Attention to Butyrylcholinesterase

  2001cited by this paper
• Acetylcholinesterase accelerates assembly of amyloid-beta-peptides into Alzheimer's fibrils: possible role of the peripheral site of the enzyme.

  1996cited by this paper
• Acetylcholinesterase, a senile plaque component, affects the fibrillogenesis of amyloid-β-peptides

  1995cited by this paper
• Acetylcholinesterase, a senile plaque component, affects the fibrillogenesis of amyloid-beta-peptides.

  1995cited by this paper
• The cholinergic hypothesis of geriatric memory dysfunction.

  1982cited by this paper
• CHANGES IN BRAIN CHOLINESTERASES IN SENILE DEMENTIA OF ALZHEIMER TYPE

  1978cited by this paper
• A new and rapid colorimetric determination of acetylcholinesterase activity.

  1961cited by this paper

• Hybrid/Chimera Drugs - Part 1 - Drug Hybrids Affecting Diseases of the Central Nervous System.

  2024cites this paper
• Genetic Targets and Applications of Iron Chelators for Neurodegeneration with Brain Iron Accumulation

  2024cites this paper
• Investigation of spirooxindole-pyrrolidine derivatives as acetylcholinesterase inhibitors using molecular docking/dynamics simulations, bioisosteric replacement, MEP, and ADME/Tox properties

  2023cites this paper
• The ethoxycarbonyl group as both activating and protective group in N-acyl-Pictet–Spengler reactions using methoxystyrenes. A short approach to racemic 1-benzyltetrahydroisoquinoline alkaloids

  2021cites this paper
• Phyto-Therapeutic and Nanomedicinal Approaches to Cure Alzheimer’s Disease: Present Status and Future Opportunities

  2018cites this paper
• Semisynthesis and biological evaluation of prenylated resveratrol derivatives as multi-targeted agents for Alzheimer’s disease

  2017cites this paper
• Erratum to: Semisynthesis and biological evaluation of prenylated resveratrol derivatives as multi-targeted agents for Alzheimer’s disease

  2017cites this paper
• Multi-Targeting Derivatives For Alzheimer’s Disease: Utilization of Quinazoline Ring Scaffolds

  2016cites this paper
• Synthesis and evaluation of benzylisoquinoline derivatives for their inhibition on pancreatic lipase and preadipocyte proliferation.

  2016cites this paper
• Recent Applications of the Multi­Target Directed Ligands Approach for the Treatment of Alzheimer's Disease

  2015cites this paper
• Synthesis and evaluation of 6-substituted 3-arylcoumarin derivatives as multifunctional acetylcholinesterase/monoamine oxidase B dual inhibitors for the treatment of Alzheimer’s disease

  2015cites this paper
• Multifunctional coumarin derivatives: monoamine oxidase B (MAO-B) inhibition, anti-β-amyloid (Aβ) aggregation and metal chelation properties against Alzheimer's disease.

  2015cites this paper
• Cognitive Enhancers (Nootropics). Part 2: Drugs Interacting with Enzymes. Update 2014

  2014cites this paper